Targeting the early steps of Aβ 16-22 protofibril disassembly by N-methylated inhibitors: A numerical study

被引:58
作者
Chebaro, Yassmine
Derreumaux, Philippe [1 ]
机构
[1] Inst Biol Phys Chim, CNRS, UPR 9080, Lab Biochim Theor, F-75005 Paris, France
关键词
amyloid simulations; protein; Alzheimer; fibril disassembly; N-methylated inhibitors; coarse-grained force field; AMYLOID FIBRIL FORMATION; FORCE-FIELD; CONGO RED; SECONDARY STRUCTURE; PEPTIDE INHIBITORS; MONTE-CARLO; AMINO-ACIDS; A-BETA(16-22); AGGREGATION; OLIGOMERS;
D O I
10.1002/prot.22254
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aggregation of the A beta 1-40/A beta 1-42 peptides is a key factor in Alzheimer's disease. Though the inhibitory effect of N-methylated A beta 16-22 (mA beta 16-22) peptides is well characterized in vitro, there is little information on how they disassemble full-length A beta fibrils or block fibril formation. Here, we report coarse-grained implicit solvent molecular dynamics (MD) and replica exchange molecular dynamics (REMD) simulations on A beta 16-22 and mA beta 16-22 monomers, and then a preformed six-chain A beta 16-22 bilayer with either four copies of A beta 16-22 or four copies of mA beta 16-22. Our simulations show that the effect of N-methylation on mA beta 16-22 monomer is to reduce the density of compact forms. While 100 ns MD trajectories do not reveal any significant differences between the two ten-chain systems, the REMD simulations totaling 1 mu s help understand the first steps of A beta 16-22 protofibril disassembly by N-methylated inhibitors. Notably, we find that mA beta 16-22 preferentially interacts with A beta 16-22 by blocking both P-sheet extension and lateral association of layers, but also by intercalation of the inhibitors allowing sequestration of A beta 16-22 peptides. This third binding mode is particularly appealing for blocking A beta fibrillogenesis.
引用
收藏
页码:442 / 452
页数:11
相关论文
共 54 条
[1]   Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease [J].
Adessi, C ;
Frossard, MJ ;
Boissard, C ;
Fraga, S ;
Bieler, S ;
Ruckle, T ;
Vilbois, F ;
Robinson, SM ;
Mutter, M ;
Banks, WA ;
Soto, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13905-13911
[2]  
[Anonymous], 2017, J MOL STRUCT, DOI DOI 10.1016/J.MOLSTRUC.2017.03.014
[3]   Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR [J].
Balbach, JJ ;
Ishii, Y ;
Antzutkin, ON ;
Leapman, RD ;
Rizzo, NW ;
Dyda, F ;
Reed, J ;
Tycko, R .
BIOCHEMISTRY, 2000, 39 (45) :13748-13759
[4]   Insight into the kinetic of amyloid β(1-42) peptide self-aggregation:: Elucidation of inhibitors' mechanism of action [J].
Bartolini, Manuela ;
Bertucci, Carlo ;
Bolognesi, Maria Laura ;
Cavalli, Andrea ;
Melchiorre, Carlo ;
Andrisano, Vincenza .
CHEMBIOCHEM, 2007, 8 (17) :2152-2161
[5]   A model for structure-dependent binding of Congo red to Alzheimer β-amyloid fibrils [J].
Carter, DB ;
Chou, KC .
NEUROBIOLOGY OF AGING, 1998, 19 (01) :37-40
[6]   Stereoselective interactions of peptide inhibitors with the β-amyloid peptide [J].
Chalifour, RJ ;
McLaughlin, RW ;
Lavoie, L ;
Morissette, C ;
Tremblay, N ;
Boulé, M ;
Sarazin, P ;
Stéa, D ;
Lacombe, D ;
Tremblay, P ;
Gervais, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34874-34881
[7]  
CHEBARO Y, REPLICA EXCHAN UNPUB
[8]   Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils [J].
Chen, ZJ ;
Krause, G ;
Reif, B .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 354 (04) :760-776
[9]   FORCE-FIELD AND VIBRATIONAL-SPECTRA OF OLIGOSACCHARIDES WITH DIFFERENT GLYCOSIDIC LINKAGES .1. TREHALOSE DIHYDRATE, SOPHOROSE MONOHYDRATE AND LAMINARIBIOSE [J].
DAUCHEZ, M ;
DERREUMAUX, P ;
LAGANT, P ;
VERGOTEN, G ;
SEKKAL, M ;
LEGRAND, P .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1994, 50 (01) :87-104
[10]  
Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO